Endometriosis is a common gynecological disease, and patients often suffer from severe dysmenorrhea, chronic pelvic pain, irregular menstruation, infertility and other problems. It is of great significance to develop safe and effective drugs for endometriosis to alleviate the suffering of patients and achieve their fertility desires.

Protheragen's main APIs for endometriosis are gonadotropin-releasing hormone (GnRH) antagonists. All our API products undergo strict quality control and comply with the standards of international regulatory agencies.

Protheragen offers a full range of APIs for endometriosis to support R&D and production for customers worldwide.